Timmerman Report
The Long Run with Luke Timmerman
"The Long Run"Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join ho...
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity 01.12.2021 1:07:11
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer 23.11.2021 1:01:11
Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
Ep102: David Baltimore Reflects on a Life in Science 08.11.2021 1:11:36
David Baltimore, professor emeritus at Caltech, reflects on a life in science.
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs 26.10.2021 1:13:16
Tony Kulesa of Petri.bio on fostering founder-led biotech companies
Ep100: Christian Henry on Long Read DNA Sequencing 13.10.2021 1:09:51
Christian Henry, CEO of PacBio, on long read DNA sequencing applications.
Ep99: Keolu Fox on Genome Sequencing of Indigenous Populations 27.09.2021 1:08:57
Keolu Fox, assistant professor at UC San Diego, on genome sequencing of indigenous populations.
Ep98: Mara Aspinall on Diagnostics and COVID-19 13.09.2021 1:07:30
Mara Aspinall of Arizona State University on diagnostics and COVID-19.
Ep97: John Evans on Base Edited Therapeutics 07.09.2021 1:11:35
John Evans, CEO of Beam Therapeutics, on base editing technology for therapeutics.
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids 09.08.2021 1:06:51
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader 26.07.2021 59:05
Sue Desmond-Hellmann on becoming a physician-scientist and biotech industry leader.
Ep94: Jenny Rooke on Investing in Biotech Tools 19.07.2021 1:11:20
Jenny Rooke of Genoa Ventures on investing in biology & technology.
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists 14.06.2021 1:33:24
Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists
Ep92: Brad Gray on Spatial Biology 01.06.2021 1:11:57
NanoString Technologies CEO Brad Gray on tools for spatial biology.
Ep91: Daphne Zohar on Biotech Entrepreneurship 03.05.2021 52:24
Daphne Zohar, CEO of Puretech Health, on starting biotech companies.
Ep90: James Sabry on Partnering Amid Scientific Abundance 19.04.2021 1:00:53
James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.
Ep89: Emily Leproust on DNA Synthesis at Scale 29.03.2021 1:04:39
Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale
Ep88: Amy DuRoss on software and logistics for cell and gene therapy 15.03.2021 1:04:47
Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing 01.03.2021 49:10
Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease 09.02.2021 1:08:59
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants 20.01.2021 47:09
Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.
Ep84: Steve Paul on Treatments for Mental Health 22.12.2020 1:09:00
Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.
Ep83: David Lee on Impact in Pharmaceuticals 14.12.2020 57:52
David Lee, CEO of Servier Pharma, on a nonprofit model.
Ep82: Andrew Farnum on Medicines From Unusual Traits 23.11.2020 58:52
Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.
Ep81: Simba Gill on Microbiome Therapies 12.11.2020 1:07:07
Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.
Ep80: Peter Kolchinsky on Pharma's Soul 28.10.2020 51:41
Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.